Dec 31, 2017

Neurocrine Biosciences Q4 2017 Earnings Report

Total Revenue
$94.5M
EPS
$0.07
Previous year: -$0.51
-113.7%
Gross Profit
$93.8M
Cash and Equivalents
$255M
Previous year: $83.3M
+205.9%
Free Cash Flow
$38.2M
Previous year: -$107M
-135.9%
Total Assets
$818M
Previous year: $365M
+123.9%

Neurocrine Biosciences

Neurocrine Biosciences